These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 23786349

  • 41. Structural and Biochemical Characterization of the Interaction of Tubulin with Potent Natural Analogues of Podophyllotoxin.
    Antúnez-Mojica M, Rodríguez-Salarichs J, Redondo-Horcajo M, León A, Barasoain I, Canales Á, Cañada FJ, Jiménez-Barbero J, Alvarez L, Díaz JF.
    J Nat Prod; 2016 Aug 26; 79(8):2113-21. PubMed ID: 27518758
    [Abstract] [Full Text] [Related]

  • 42. Novel shikonin derivatives targeting tubulin as anticancer agents.
    Guo J, Chen XF, Liu J, Lin HY, Han HW, Liu HC, Huang SC, Shahla BK, Kulek A, Qi JL, Wang XM, Ling LJ, Yang YH.
    Chem Biol Drug Des; 2014 Nov 26; 84(5):603-15. PubMed ID: 24797889
    [Abstract] [Full Text] [Related]

  • 43. 3-substituted 2-phenylimidazo[2,1-b]benzothiazoles: synthesis, anticancer activity, and inhibition of tubulin polymerization.
    Kamal A, Sultana F, Ramaiah MJ, Srikanth YV, Viswanath A, Kishor C, Sharma P, Pushpavalli SN, Addlagatta A, Pal-Bhadra M.
    ChemMedChem; 2012 Feb 06; 7(2):292-300. PubMed ID: 22241597
    [Abstract] [Full Text] [Related]

  • 44. Discover 4β-NH-(6-aminoindole)-4-desoxy-podophyllotoxin with nanomolar-potency antitumor activity by improving the tubulin binding affinity on the basis of a potential binding site nearby colchicine domain.
    Zhao W, He L, Xiang TL, Tang YJ.
    Eur J Med Chem; 2019 May 15; 170():73-86. PubMed ID: 30878833
    [Abstract] [Full Text] [Related]

  • 45. Synthesis and biological evaluation of 2-amino-3-(3',4',5'-trimethoxybenzoyl)-5-aryl thiophenes as a new class of potent antitubulin agents.
    Romagnoli R, Baraldi PG, Pavani MG, Tabrizi MA, Preti D, Fruttarolo F, Piccagli L, Jung MK, Hamel E, Borgatti M, Gambari R.
    J Med Chem; 2006 Jun 29; 49(13):3906-15. PubMed ID: 16789746
    [Abstract] [Full Text] [Related]

  • 46. Synthesis, molecular modeling and biological evaluation of dithiocarbamates as novel antitubulin agents.
    Qian Y, Ma GY, Yang Y, Cheng K, Zheng QZ, Mao WJ, Shi L, Zhao J, Zhu HL.
    Bioorg Med Chem; 2010 Jun 15; 18(12):4310-6. PubMed ID: 20493717
    [Abstract] [Full Text] [Related]

  • 47. Development of a novel class of tubulin inhibitors with promising anticancer activities.
    Xi J, Zhu X, Feng Y, Huang N, Luo G, Mao Y, Han X, Tian W, Wang G, Han X, Luo R, Huang Z, An J.
    Mol Cancer Res; 2013 Aug 15; 11(8):856-64. PubMed ID: 23666368
    [Abstract] [Full Text] [Related]

  • 48. Design and synthesis of imidazo[2,1-b]thiazole-chalcone conjugates: microtubule-destabilizing agents.
    Kamal A, Balakrishna M, Nayak VL, Shaik TB, Faazil S, Nimbarte VD.
    ChemMedChem; 2014 Dec 15; 9(12):2766-80. PubMed ID: 25313981
    [Abstract] [Full Text] [Related]

  • 49. Design, synthesis, biological evaluation and molecular modeling of 1,3,4-oxadiazoline analogs of combretastatin-A4 as novel antitubulin agents.
    Hu Y, Lu X, Chen K, Yan R, Li QS, Zhu HL.
    Bioorg Med Chem; 2012 Jan 15; 20(2):903-9. PubMed ID: 22192936
    [Abstract] [Full Text] [Related]

  • 50. Tubulin structure-based drug design for the development of novel 4β-sulfur-substituted podophyllum tubulin inhibitors with anti-tumor activity.
    Zhao W, Bai JK, Li HM, Chen T, Tang YJ.
    Sci Rep; 2015 May 11; 5():10172. PubMed ID: 25959922
    [Abstract] [Full Text] [Related]

  • 51. Generation of ligand-based pharmacophore model and virtual screening for identification of novel tubulin inhibitors with potent anticancer activity.
    Chiang YK, Kuo CC, Wu YS, Chen CT, Coumar MS, Wu JS, Hsieh HP, Chang CY, Jseng HY, Wu MH, Leou JS, Song JS, Chang JY, Lyu PC, Chao YS, Wu SY.
    J Med Chem; 2009 Jul 23; 52(14):4221-33. PubMed ID: 19507860
    [Abstract] [Full Text] [Related]

  • 52. Chemical synthesis, pharmacological evaluation and in silico analysis of new 2,3,3a,4,5,6-hexahydrocyclopenta[c]pyrazole derivatives as potential anti-mitotic agents.
    Minu M, Singh D, Mahaddalkar T, Lopus M, Winter P, Ayoub AT, Missiaen K, Tilli TM, Pasdar M, Tuszynski J.
    Bioorg Med Chem Lett; 2016 Aug 15; 26(16):3855-61. PubMed ID: 27449957
    [Abstract] [Full Text] [Related]

  • 53. Synthesis and biological evaluation of heterocyclic carboxylic acyl shikonin derivatives.
    Wang XM, Lin HY, Kong WY, Guo J, Shi J, Huang SC, Qi JL, Yang RW, Gu HW, Yang YH.
    Chem Biol Drug Des; 2014 Mar 15; 83(3):334-43. PubMed ID: 24118825
    [Abstract] [Full Text] [Related]

  • 54. Cytotoxic activity of a synthetic deoxypodophyllotoxin derivative with an opened D-ring.
    Chen C, Wang CC, Wang Z, Geng WY, Xu H, Song XM, Luo DQ.
    J Asian Nat Prod Res; 2016 May 15; 18(5):486-94. PubMed ID: 27123550
    [Abstract] [Full Text] [Related]

  • 55. Synthesis of aryl dihydrothiazol acyl shikonin ester derivatives as anticancer agents through microtubule stabilization.
    Lin HY, Li ZK, Bai LF, Baloch SK, Wang F, Qiu HY, Wang X, Qi JL, Yang RW, Wang XM, Yang YH.
    Biochem Pharmacol; 2015 Jul 15; 96(2):93-106. PubMed ID: 25957661
    [Abstract] [Full Text] [Related]

  • 56. Design, synthesis, and biological evaluation of thiophene analogues of chalcones.
    Romagnoli R, Baraldi PG, Carrion MD, Cara CL, Cruz-Lopez O, Preti D, Tolomeo M, Grimaudo S, Di Cristina A, Zonta N, Balzarini J, Brancale A, Sarkar T, Hamel E.
    Bioorg Med Chem; 2008 May 15; 16(10):5367-76. PubMed ID: 18440234
    [Abstract] [Full Text] [Related]

  • 57. Synthesis, biological evaluation, and molecular docking studies of 2,6-dinitro-4-(trifluoromethyl)phenoxysalicylaldoxime derivatives as novel antitubulin agents.
    Zhao TT, Lu X, Yang XH, Wang LM, Li X, Wang ZC, Gong HB, Zhu HL.
    Bioorg Med Chem; 2012 May 15; 20(10):3233-41. PubMed ID: 22512906
    [Abstract] [Full Text] [Related]

  • 58. Synthesis, molecular docking and biological evaluation of 1-phenylsulphonyl-2-(1-methylindol-3-yl)-benzimidazole derivatives as novel potential tubulin assembling inhibitors.
    Wang YT, Cai XC, Shi TQ, Zhang YL, Wang ZC, Liu CH, Zhu HL.
    Chem Biol Drug Des; 2017 Jul 15; 90(1):112-118. PubMed ID: 28032450
    [Abstract] [Full Text] [Related]

  • 59. Brine shrimp lethality assay 'an effective prescreen': microwave-assisted synthesis, BSL toxicity and 3DQSAR studies-based designing, docking and antitumor evaluation of potent chalcones.
    Nazir S, Ansari FL, Hussain T, Mazhar K, Muazzam AG, Qasmi ZU, Makhmoor T, Noureen H, Mirza B.
    Pharm Biol; 2013 Sep 15; 51(9):1091-103. PubMed ID: 23745524
    [Abstract] [Full Text] [Related]

  • 60. Synthesis and biological evaluation of indole-2-carbohydrazides and thiazolidinyl-indole-2-carboxamides as potent tubulin polymerization inhibitors.
    Kazan F, Yagci ZB, Bai R, Ozkirimli E, Hamel E, Ozkirimli S.
    Comput Biol Chem; 2019 Jun 15; 80():512-523. PubMed ID: 31185422
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.